Clinical Trial Update: Biased GRK Signaling Via β2-Adrenergic Receptors in Human Skeletal Muscle [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining biased GRK signaling via β2-adrenergic receptors in human skeletal muscle as a potential approach for overweight and o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Snippet

Sponsor: Morten Hostrup, PhD | Conditions: Overweight and Obesity | Phase 2 | Status: NOT_YET_RECRUITING